Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 69)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
30-Nov-09 Freedonia Group Inc, The The Freedonia Group Freedonia Focus on Cancer Therapies 23 $500 View Abstract
24-Nov-09 New Constructs, LLC N/A LLY: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
23-Nov-09 Reuters Investment Profile N/A Eli Lilly and Co: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Trends, Statistics & Analysis 2009 (Summary) 34 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Eli Lilly & Company (LLY) Profile & Biotech Industry Trends Analysis 2010 43 $149 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Market Research and Competitive Analysis 2009 447 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Engineering & Research Industry Market Research and Competitive Analysis 2009 729 $299 View Abstract
Next 20

Brokerage Reports (Showing 1 to 10 of 13)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
10-Nov-09 Thomson StreetEvents N/A LLY - Event Transcript of Eli Lilly conference call, Nov. 09, 2009 / 2:30pm ET 18 $75 View Abstract
5-Nov-09 First Global Kavita Thomas, Devina Mehra First Global reiterates MarketPerform on GlaxoSmithKline Plc. 12 $25 View Abstract
24-Oct-09 First Global Kavita Thomas, Devina Mehra First Global reiterates ST MarketPerform on Eli Lilly & Co. 13 $50 View Abstract
23-Oct-09 First Global Kavita Thomas, Devina Mehra First Global reiterates MarketPerform on Merck & Co. (MRK) 12 $25 View Abstract
22-Oct-09 First Global Kavita Thomas, Devina Mehra First Global reiterates Moderate Outperform on Pfizer Inc 12 $25 View Abstract
22-Oct-09 Caris & Company David Moskowitz LLY-Maintain 2*/Above Average, Reducing Target 9 $25 View Abstract
21-Oct-09 Hilliard Lyons Stephen A. O'Neil 3Q EPS Well Ahead of Expectations on Strong Volume and Margin Improvement 7 $25 View Abstract
21-Oct-09 Thomson StreetEvents N/A LLY - Q3 2009 Eli Lilly Earnings Conference Call 18 $75 View Abstract
21-Oct-09 Thomson StreetEvents N/A LLY - Event Transcript of Eli Lilly conference call, Oct. 21, 2009 / 9:00am ET 27 $75 View Abstract
21-Oct-09 Thomson StreetEvents N/A LLY - Event Brief of Eli Lilly conference call, Oct. 21, 2009 / 9:00am ET 8 $75 View Abstract
Next 3

Independent Reports (Showing 1 to 10 of 56)

Release
Date Contributor Author Title Pages Price More Info
30-Nov-09 Freedonia Group Inc, The The Freedonia Group Freedonia Focus on Cancer Therapies 23 $500 View Abstract
24-Nov-09 New Constructs, LLC N/A LLY: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
23-Nov-09 Reuters Investment Profile N/A Eli Lilly and Co: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Trends, Statistics & Analysis 2009 (Summary) 34 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Eli Lilly & Company (LLY) Profile & Biotech Industry Trends Analysis 2010 43 $149 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Market Research and Competitive Analysis 2009 447 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Engineering & Research Industry Market Research and Competitive Analysis 2009 729 $299 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.